Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Jakarta - Delayed Quote IDR

PT Darya-Varia Laboratoria Tbk (DVLA.JK)

Compare
1,420.00
-10.00
(-0.70%)
At close: April 11 at 4:13:45 PM GMT+7
Loading Chart for DVLA.JK
  • Previous Close 1,430.00
  • Open 1,430.00
  • Bid 1,410.00 x --
  • Ask 1,425.00 x --
  • Day's Range 1,400.00 - 1,435.00
  • 52 Week Range 1,325.00 - 1,850.00
  • Volume 9,900
  • Avg. Volume 38,234
  • Market Cap (intraday) 1.59T
  • Beta (5Y Monthly) -0.14
  • PE Ratio (TTM) 10.18
  • EPS (TTM) 139.44
  • Earnings Date --
  • Forward Dividend & Yield 108.00 (7.61%)
  • Ex-Dividend Date Nov 1, 2024
  • 1y Target Est --

PT Darya-Varia Laboratoria Tbk engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company provides prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear healthcare, and central nerve systems. It also offers Consumer Health products comprising Skin Nutrition under the Natur-E brand; Respiratory products under the Decolgen, ALLERIN EXPECTORANT, Decolsin, NEOZEP, STOP COLD, SILEX, and HERBABLEND brand names for nasal congestion, cough, as well as breathing issues caused by allergy; multivitamins under the Enervon-C, Enervon Active, Enervon Gold, and Supertin brands; vitamin C under the Vicee brand; and supplement for kids with Zinc and vitamin C under the Imunped brand; Biogesic for various types of pain; Diatabs, a anti diarrhea product; and New Enzyplex to prevent indigestion. In addition, the company offers toll manufacturing services for soft gelatin capsules, and sterile injections and low volume solid products. It also exports its products to Malaysia, Myanmar, the Philippines, Singapore, Vietnam, and Mongolia. The company was founded in 1976 and is headquartered in Jakarta, Indonesia. PT Darya-Varia Laboratoria Tbk is a subsidiary of Blue Sphere Singapore Pte. Ltd.

www.darya-varia.com

1,270

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DVLA.JK

View More

Performance Overview: DVLA.JK

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .

YTD Return

DVLA.JK
11.25%
IDX COMPOSITE (^JKSE)
11.55%

1-Year Return

DVLA.JK
4.14%
IDX COMPOSITE (^JKSE)
14.06%

3-Year Return

DVLA.JK
36.01%
IDX COMPOSITE (^JKSE)
13.07%

5-Year Return

DVLA.JK
9.97%
IDX COMPOSITE (^JKSE)
34.70%

Compare To: DVLA.JK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DVLA.JK

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    1.59T

  • Enterprise Value

    1.23T

  • Trailing P/E

    10.19

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.76

  • Price/Book (mrq)

    1.10

  • Enterprise Value/Revenue

    0.59

  • Enterprise Value/EBITDA

    5.01

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.48%

  • Return on Assets (ttm)

    5.94%

  • Return on Equity (ttm)

    10.94%

  • Revenue (ttm)

    2.09T

  • Net Income Avi to Common (ttm)

    156.15B

  • Diluted EPS (ttm)

    139.44

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    357.82B

  • Total Debt/Equity (mrq)

    0.07%

  • Levered Free Cash Flow (ttm)

    183.63B

Research Analysis: DVLA.JK

View More

Company Insights: DVLA.JK

Research Reports: DVLA.JK

View More

People Also Watch